TriSalus Life Sciences, Inc.

TLSI

TLSITriSalus Life Sciences, Inc. US flag

NASDAQ Global Market

4.30

USD

+0.53

- -

162.82MMarket Cap

Profitability (USD)

MCP API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-157.73	-254.82	-123.72	-132.3
Return on Capital (%)	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -
Gross Margin (%)	85.8	81.79	85.93	86.06	84.57
EBITDA Margin (%)	-280.54	-290.7	-290.59	-120.35	-58.29
Operating Margin (%)	-286.06	-293.91	-294.28	-122.88	-59.68
Incremental Operating Margin (%)	- -	- -	- -	- -	- -
Pretax Margin (%)	-343.32	-380.53	-320.64	-102.07	-86.86
Profit Margin (%)	-343.35	-380.6	-320.69	-102.09	-86.88
Net Income to Common Margin (%)	-343.35	-403.42	-327.49	-112.92	-86.88
Effective Tax Rate (%)	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	5.66	2.08	9.59	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -

Credit (USD)

MCP API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	2	2	24	34
ST Debt	- -	- -	- -	- -	- -
LT Debt	- -	2	1	23	34
Total Debt/EBITDA	- -	-0.05	-0.03	-0.67	-1.31
Net Debt/EBITDA	1.29	0.26	0.22	-0.38	-0.48
Total Debt/EBIT	- -	-0.05	-0.03	-0.65	-1.28
Net Debt/EBIT	1.26	0.26	0.22	-0.37	-0.47
EBITDA to Interest Expense	-13.38	-36,041	-3,361.94	-11.46	-4.75
EBITDA-CapEx/Interest Expense	-14.1	-36,827	-3,432	-11.57	-4.91
EBIT to Interest Expense	-13.65	-36,439	-3,404.69	-11.7	-4.86
Interest Expense	2	- -	- -	3	6
Common Equity/Total Assets	-360.31	-847.27	-1,014.32	-1,166.18	-935.66
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	-0.86	-0.5	-9.15	-11.57
Long-Term Debt/Total Assets (%)	- -	7.24	5.06	97.67	97.01
Total Debt/Equity (%)	- -	-1.11	-5.89	-91.25	-101.71
Total Debt/Capital (%)	- -	-1.06	-0.64	-9.23	-11.63
Total Debt/Total Assets (%)	- -	8.92	6.48	98.57	97.48
Net Debt to Equity	23.38	5.34	43.51	-52.36	-37.23
Net Debt/Capital (%)	18.18	4.86	4.54	-5.13	-3.98
EBITDA	-24	-36	-54	-35	-26
EBITDA-CapEx	-25	-37	-55	-36	-27
Operating Income (Loss)	-24	-36	-54	-36	-27

Liquidity (USD)

MCP API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	4.75	0.29	0.8	0.83	1.78
Current Ratio	5.51	0.53	1.42	2.02	2.8
Quick Ratio	4.97	0.34	1.04	1.33	2.35
CFO/Avg Current Liab	- -	-1.67	-2.15	-3.28	-1.66
Common Equity/Total Assets	-360.31	-847.27	-1,014.32	-1,166.18	-935.66
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	-0.86	-0.5	-9.15	-11.57
Long-Term Debt/Total Assets (%)	- -	7.24	5.06	97.67	97.01
Total Debt/Equity (%)	- -	-1.11	-5.89	-91.25	-101.71
Total Debt/Capital (%)	- -	-1.06	-0.64	-9.23	-11.63
Total Debt/Total Assets (%)	- -	8.92	6.48	98.57	97.48
CFO/Total Liabilities	-13.56	-16.29	-97.9	-81.91	-26.03
CFO/CapEx	-18.04	-41.11	-45.12	-118.39	-19.62
Altman's Z-Score	-6.12	-18.25	-20.52	-18.03	-11.34

Working Capital (USD)

MCP API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	8.51	7.24	6.81	7.75
Days Sales Outstanding	- -	42.89	50.39	53.58	47.07
Inventory Turnover	- -	1.63	1.3	1.24	1.96
Days Inventory Outstanding	- -	223.32	281.35	293.25	186.69
Accounts Payable Turnover	- -	0.78	0.88	1.98	2.27
Accounts Payable Turnover Days	- -	467.82	413.61	184.42	160.64
Cash Conversion Cycle	- -	-201.61	-81.87	162.42	73.12
Inventory to Cash Days	- -	-180.42	-230.96	-239.67	-139.62
Inventories	1	1	3	4	3
Raw Materials	1	1	1	1	1
Work In Process	- -	- -	- -	- -	- -
Finished Goods	1	1	2	3	2
Other Inventory	- -	- -	- -	- -	- -

Enterprise Value (USD)

MCP API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	3	3	79	127	265
- Cash & Cash Equivalents	30	9	12	9	20
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -
+ Total Debt	- -	2	2	24	34
Enterprise Value	-27	-4	69	142	279
Total Capital	-136	-184	-248	-256	-296
Total Debt/Capital (%)	- -	-1.06	-0.64	-9.23	-11.63
Total Debt / EV	- -	-0.45	0.02	0.17	0.12
EV/Sales	- -	- -	3.74	4.83	6.17
EV/EBITDA	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -
Diluted Market Cap	3	3	79	127	265
Diluted Enterprise Value	-27	-4	69	142	279
EV per Share	- -	- -	7.37	5.61	7.35
TTM Sales	8	12	19	29	45
TTM EBITDA	-24	-36	-54	-35	-26
TTM Operating Income	-24	-36	-54	-36	-27
TTM Cash Flow to Firm	-21	-32	-51	-38	-12
TTM Free Cash Flow to Firm	-20	-32	-49	-37	-12

Multiples (USD)

MCP API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-0.14	-0.1	-1.61	-3.13	-15.47
EV/EBIT	- -	- -	- -	- -	- -
Enterprise Value	-27	-4	69	142	279
Low Price	9.45	8.99	3.32	3.5	3.42
EV/Sales	- -	- -	3.74	4.83	6.17
EV/EBITDA	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -
Price/Earnings Average	-0.11	-0.06	-1.32	-5.16	-5.06
Price/Earnings High	-0.12	-0.07	-2.52	-7.94	-7.68
Price/Earnings Low	-0.1	-0.06	-0.51	-2.67	-3.3
Price/Book Value	-0.02	-0.02	-0.32	-0.45	-0.8
Price/Book Value Average	-0.02	-0.02	-0.32	-0.61	-0.6
Price/Book Value High	-0.03	-0.02	-0.61	-0.94	-0.91
Price/Book Value Low	-0.02	-0.01	-0.13	-0.32	-0.39
Price/Tangible Book Value	-0.02	-0.02	-2.82	-4.9	-7.81
Price/Tangible Book Value Average	-0.02	-0.02	-2.83	-6.63	-5.86
Price/Tangible Book Value High	-0.03	-0.02	-5.41	-10.19	-8.9
Price/Tangible Book Value Low	-0.02	-0.02	-1.11	-3.42	-3.83
Price/Sales	0.36	0.25	4.29	4.31	5.86
Price/Sales Average	0.36	0.25	4.32	5.83	4.4
Price/Sales High	0.41	0.27	8.24	8.97	6.67
Price/Sales Low	0.35	0.22	1.69	3.01	2.87
Price/Cash Flow	-0.13	-0.1	-1.57	-3.11	-14.69
Price/Cash Flow Average	-0.13	-0.09	-1.58	-4.2	-11.03
Price/Cash Flow High	-0.15	-0.1	-3.02	-6.46	-16.73
Price/Cash Flow Low	-0.13	-0.09	-0.62	-2.17	-7.2
Price/Free Cash Flow Average	-0.14	-0.1	-1.62	-4.24	-11.62
Price/Free Cash Flow High	-0.16	-0.1	-3.09	-6.52	-17.63
Price/Free Cash Flow Low	-0.14	-0.09	-0.63	-2.19	-7.58
EV/Sales Average	- -	- -	3.77	6.34	4.71
EV/Sales High	- -	- -	7.69	9.48	6.98
EV/Sales Low	- -	- -	1.14	3.53	3.18
EV/EBITDA Average	1.16	0.12	-1.3	-5.27	-8.08
EV/EBITDA High	1.14	0.11	-2.65	-7.88	-11.98
EV/EBITDA Low	1.16	0.13	-0.39	-2.93	-5.46
EV/EBIT Average	1.13	0.12	-1.28	-5.16	-7.89
EV/EBIT High	1.12	0.11	-2.61	-7.72	-11.7
EV/EBIT Low	1.14	0.13	-0.39	-2.87	-5.33
Last Price	9.88	10.03	8.45	5.01	6.98
High Price	11.18	10.68	16.24	10.42	7.95
Enterprise Value Average	-27	-4	70	187	213
Enterprise Value High	-27	-4	142	279	315
Enterprise Value Low	-27	-5	21	104	144

Profitability (USD)

MCP API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-157.73	-254.82	-123.72	-132.3
Return on Capital (%)	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -
Gross Margin (%)	85.8	81.79	85.93	86.06	84.57
EBITDA Margin (%)	-280.54	-290.7	-290.59	-120.35	-58.29
Operating Margin (%)	-286.06	-293.91	-294.28	-122.88	-59.68
Incremental Operating Margin (%)	- -	- -	- -	- -	- -
Pretax Margin (%)	-343.32	-380.53	-320.64	-102.07	-86.86
Profit Margin (%)	-343.35	-380.6	-320.69	-102.09	-86.88
Net Income to Common Margin (%)	-343.35	-403.42	-327.49	-112.92	-86.88
Effective Tax Rate (%)	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	5.66	2.08	9.59	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -

Credit (USD)

MCP API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	2	2	24	34
ST Debt	- -	- -	- -	- -	- -
LT Debt	- -	2	1	23	34
Total Debt/EBITDA	- -	-0.05	-0.03	-0.67	-1.31
Net Debt/EBITDA	1.29	0.26	0.22	-0.38	-0.48
Total Debt/EBIT	- -	-0.05	-0.03	-0.65	-1.28
Net Debt/EBIT	1.26	0.26	0.22	-0.37	-0.47
EBITDA to Interest Expense	-13.38	-36,041	-3,361.94	-11.46	-4.75
EBITDA-CapEx/Interest Expense	-14.1	-36,827	-3,432	-11.57	-4.91
EBIT to Interest Expense	-13.65	-36,439	-3,404.69	-11.7	-4.86
Interest Expense	2	- -	- -	3	6
Common Equity/Total Assets	-360.31	-847.27	-1,014.32	-1,166.18	-935.66
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	-0.86	-0.5	-9.15	-11.57
Long-Term Debt/Total Assets (%)	- -	7.24	5.06	97.67	97.01
Total Debt/Equity (%)	- -	-1.11	-5.89	-91.25	-101.71
Total Debt/Capital (%)	- -	-1.06	-0.64	-9.23	-11.63
Total Debt/Total Assets (%)	- -	8.92	6.48	98.57	97.48
Net Debt to Equity	23.38	5.34	43.51	-52.36	-37.23
Net Debt/Capital (%)	18.18	4.86	4.54	-5.13	-3.98
EBITDA	-24	-36	-54	-35	-26
EBITDA-CapEx	-25	-37	-55	-36	-27
Operating Income (Loss)	-24	-36	-54	-36	-27

Liquidity (USD)

MCP API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	4.75	0.29	0.8	0.83	1.78
Current Ratio	5.51	0.53	1.42	2.02	2.8
Quick Ratio	4.97	0.34	1.04	1.33	2.35
CFO/Avg Current Liab	- -	-1.67	-2.15	-3.28	-1.66
Common Equity/Total Assets	-360.31	-847.27	-1,014.32	-1,166.18	-935.66
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	-0.86	-0.5	-9.15	-11.57
Long-Term Debt/Total Assets (%)	- -	7.24	5.06	97.67	97.01
Total Debt/Equity (%)	- -	-1.11	-5.89	-91.25	-101.71
Total Debt/Capital (%)	- -	-1.06	-0.64	-9.23	-11.63
Total Debt/Total Assets (%)	- -	8.92	6.48	98.57	97.48
CFO/Total Liabilities	-13.56	-16.29	-97.9	-81.91	-26.03
CFO/CapEx	-18.04	-41.11	-45.12	-118.39	-19.62
Altman's Z-Score	-6.12	-18.25	-20.52	-18.03	-11.34

Working Capital (USD)

MCP API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	8.51	7.24	6.81	7.75
Days Sales Outstanding	- -	42.89	50.39	53.58	47.07
Inventory Turnover	- -	1.63	1.3	1.24	1.96
Days Inventory Outstanding	- -	223.32	281.35	293.25	186.69
Accounts Payable Turnover	- -	0.78	0.88	1.98	2.27
Accounts Payable Turnover Days	- -	467.82	413.61	184.42	160.64
Cash Conversion Cycle	- -	-201.61	-81.87	162.42	73.12
Inventory to Cash Days	- -	-180.42	-230.96	-239.67	-139.62
Inventories	1	1	3	4	3
Raw Materials	1	1	1	1	1
Work In Process	- -	- -	- -	- -	- -
Finished Goods	1	1	2	3	2
Other Inventory	- -	- -	- -	- -	- -

Enterprise Value (USD)

MCP API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	3	3	79	127	265
- Cash & Cash Equivalents	30	9	12	9	20
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -
+ Total Debt	- -	2	2	24	34
Enterprise Value	-27	-4	69	142	279
Total Capital	-136	-184	-248	-256	-296
Total Debt/Capital (%)	- -	-1.06	-0.64	-9.23	-11.63
Total Debt / EV	- -	-0.45	0.02	0.17	0.12
EV/Sales	- -	- -	3.74	4.83	6.17
EV/EBITDA	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -
Diluted Market Cap	3	3	79	127	265
Diluted Enterprise Value	-27	-4	69	142	279
EV per Share	- -	- -	7.37	5.61	7.35
TTM Sales	8	12	19	29	45
TTM EBITDA	-24	-36	-54	-35	-26
TTM Operating Income	-24	-36	-54	-36	-27
TTM Cash Flow to Firm	-21	-32	-51	-38	-12
TTM Free Cash Flow to Firm	-20	-32	-49	-37	-12

Multiples (USD)

MCP API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-0.14	-0.1	-1.61	-3.13	-15.47
EV/EBIT	- -	- -	- -	- -	- -
Enterprise Value	-27	-4	69	142	279
Low Price	9.45	8.99	3.32	3.5	3.42
EV/Sales	- -	- -	3.74	4.83	6.17
EV/EBITDA	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -
Price/Earnings Average	-0.11	-0.06	-1.32	-5.16	-5.06
Price/Earnings High	-0.12	-0.07	-2.52	-7.94	-7.68
Price/Earnings Low	-0.1	-0.06	-0.51	-2.67	-3.3
Price/Book Value	-0.02	-0.02	-0.32	-0.45	-0.8
Price/Book Value Average	-0.02	-0.02	-0.32	-0.61	-0.6
Price/Book Value High	-0.03	-0.02	-0.61	-0.94	-0.91
Price/Book Value Low	-0.02	-0.01	-0.13	-0.32	-0.39
Price/Tangible Book Value	-0.02	-0.02	-2.82	-4.9	-7.81
Price/Tangible Book Value Average	-0.02	-0.02	-2.83	-6.63	-5.86
Price/Tangible Book Value High	-0.03	-0.02	-5.41	-10.19	-8.9
Price/Tangible Book Value Low	-0.02	-0.02	-1.11	-3.42	-3.83
Price/Sales	0.36	0.25	4.29	4.31	5.86
Price/Sales Average	0.36	0.25	4.32	5.83	4.4
Price/Sales High	0.41	0.27	8.24	8.97	6.67
Price/Sales Low	0.35	0.22	1.69	3.01	2.87
Price/Cash Flow	-0.13	-0.1	-1.57	-3.11	-14.69
Price/Cash Flow Average	-0.13	-0.09	-1.58	-4.2	-11.03
Price/Cash Flow High	-0.15	-0.1	-3.02	-6.46	-16.73
Price/Cash Flow Low	-0.13	-0.09	-0.62	-2.17	-7.2
Price/Free Cash Flow Average	-0.14	-0.1	-1.62	-4.24	-11.62
Price/Free Cash Flow High	-0.16	-0.1	-3.09	-6.52	-17.63
Price/Free Cash Flow Low	-0.14	-0.09	-0.63	-2.19	-7.58
EV/Sales Average	- -	- -	3.77	6.34	4.71
EV/Sales High	- -	- -	7.69	9.48	6.98
EV/Sales Low	- -	- -	1.14	3.53	3.18
EV/EBITDA Average	1.16	0.12	-1.3	-5.27	-8.08
EV/EBITDA High	1.14	0.11	-2.65	-7.88	-11.98
EV/EBITDA Low	1.16	0.13	-0.39	-2.93	-5.46
EV/EBIT Average	1.13	0.12	-1.28	-5.16	-7.89
EV/EBIT High	1.12	0.11	-2.61	-7.72	-11.7
EV/EBIT Low	1.14	0.13	-0.39	-2.87	-5.33
Last Price	9.88	10.03	8.45	5.01	6.98
High Price	11.18	10.68	16.24	10.42	7.95
Enterprise Value Average	-27	-4	70	187	213
Enterprise Value High	-27	-4	142	279	315
Enterprise Value Low	-27	-5	21	104	144

Shares Outstanding	26	26	26	31	50
Diluted Weighted Avg Shares	- -	- -	9	25	38
Basic Weighted Avg Shares	- -	- -	9	25	38
Revenue per Share	27.13	40.04	1.97	1.16	1.19
EBITDA per Share	-76.12	-116.41	-5.73	-1.4	-0.69
Operating Income per Share	-77.62	-117.69	-5.8	-1.43	-0.71
Basic EPS, GAAP	-93.17	-161.55	-6.45	-1.31	-1.04
Basic EPS from Cont Ops	-93.17	-152.41	-6.32	-1.19	-1.04
Diluted EPS, GAAP	-93.17	-161.55	-6.45	-1.31	-1.04
Diluted EPS from Cont Ops	-93.17	-152.41	-6.32	-1.19	-1.04
Dividend per Share	- -	- -	- -	- -	- -
Cash Flow per Share	-73.31	-104.37	-5.38	-1.61	-0.48
Free Cash Flow per Basic Share	-77.37	-106.91	-5.5	-1.63	-0.5
Cash & Equivalents per Share	97.87	30.41	1.25	0.34	0.54
Book Value per Share	-440.33	-601.91	-26.55	-11.04	-8.72
Tangible Book Value per Share	-421.17	-572.12	-3	-1.02	-0.89

TriSalus Life Sciences, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)